Neuronetics Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
STIM Nasdaq 3845 https://neurostar.com/neuronetics/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neuronetics Inc

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital - Apr 10th, 2024 12:31 pm
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression - Apr 1st, 2024 2:52 pm
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Mar 27th, 2024 8:30 pm
Neuronetics wins FDA clearance for device to treat adolescents with depression - Mar 27th, 2024 5:10 am
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression - Mar 25th, 2024 12:30 pm
Neuronetics (STIM) Progresses in MRD and TRD With New Deal - Mar 8th, 2024 1:06 pm
Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023 - Mar 7th, 2024 7:00 pm
Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript - Mar 7th, 2024 3:16 pm
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network - Mar 7th, 2024 1:22 pm
Neuronetics Full Year 2023 Earnings: US$1.05 loss per share (vs US$1.38 loss in FY 2022) - Mar 6th, 2024 10:18 am
Q4 2023 Neuronetics Inc Earnings Call - Mar 6th, 2024 4:39 am
Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates - Mar 5th, 2024 1:40 pm
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results - Mar 5th, 2024 12:30 pm
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call - Feb 20th, 2024 1:30 pm
Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates - Feb 15th, 2024 10:35 pm
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System - Feb 12th, 2024 1:32 pm
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update - Feb 6th, 2024 1:28 pm
After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain - Jan 23rd, 2024 10:15 am
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results - Jan 8th, 2024 1:30 pm
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory - Dec 18th, 2023 1:49 pm